Q3 2024 EPS Estimates for Option Care Health, Inc. Lowered by Analyst (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCHFree Report) – Equities researchers at William Blair lowered their Q3 2024 earnings per share estimates for Option Care Health in a research report issued on Wednesday, April 24th. William Blair analyst M. Larew now forecasts that the company will earn $0.31 per share for the quarter, down from their prior estimate of $0.32. The consensus estimate for Option Care Health’s current full-year earnings is $1.17 per share. William Blair also issued estimates for Option Care Health’s Q4 2024 earnings at $0.35 EPS.

Other equities analysts have also issued reports about the company. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research note on Wednesday. Jefferies Financial Group increased their price target on Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th.

View Our Latest Research Report on OPCH

Option Care Health Stock Performance

NASDAQ OPCH opened at $29.29 on Friday. The firm has a market cap of $5.09 billion, a price-to-earnings ratio of 19.27, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average price of $32.04 and a 200-day moving average price of $31.50. Option Care Health has a twelve month low of $24.23 and a twelve month high of $35.74.

Option Care Health (NASDAQ:OPCHGet Free Report) last released its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The business had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. Option Care Health’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.21 earnings per share.

Institutional Trading of Option Care Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. New York State Teachers Retirement System raised its stake in Option Care Health by 1.4% in the 1st quarter. New York State Teachers Retirement System now owns 120,555 shares of the company’s stock worth $4,043,000 after acquiring an additional 1,700 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Option Care Health by 0.9% in the 1st quarter. Assenagon Asset Management S.A. now owns 828,970 shares of the company’s stock worth $27,804,000 after acquiring an additional 7,043 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in Option Care Health by 2.6% in the 1st quarter. Louisiana State Employees Retirement System now owns 51,000 shares of the company’s stock worth $1,711,000 after acquiring an additional 1,300 shares during the last quarter. Norden Group LLC raised its stake in Option Care Health by 1,043.1% in the 1st quarter. Norden Group LLC now owns 121,592 shares of the company’s stock worth $4,078,000 after acquiring an additional 110,955 shares during the last quarter. Finally, Lifestyle Asset Management Inc. purchased a new position in Option Care Health in the 1st quarter worth $211,000. Institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The shares were bought at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares in the company, valued at $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by insiders.

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Earnings History and Estimates for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.